>
Fa
|
Ar
|
En
iranian journal of blood and cancer
سال:2011 - دوره:3 - شماره:3
Access and Rational use of Plasma Protein Therapies (PPTs)
- صفحه:151-158
Clinical application of plasma derived medicines: current situation and future trend
- صفحه:159-169
Hyperimmunes Plasma Procurement and Products
- صفحه:147-149
Making plasma derived medicines available
- صفحه:121-129
Message of President of ISBT to 2nd International Conference on Transfusion Medicine/Plasma Industry in Tehran, Iran, May 10-11, 2011
- صفحه:97-98
Pathogen Reduction of Plasma
- صفحه:183-187
Patients Perspective in Plasma Products (Focus on Hemophilia)
- صفحه:171-175
Plasma Fractionation Industry Project in Turkey: Country’s Experiences
- صفحه:177-182
Plasma Fractionation in Malaysia
- صفحه:107-110
Plasma derived versus biotechnological manufactured medicine
- صفحه:131-137
Quality Assurance and Good Manufacturing Practice in Respect of Plasma Fractionation
- صفحه:139-146
Securing Safe Plasma for Fractionation the Duty of any Country
- صفحه:189-196
Self Sufficiency In Plasma And Plasma Derived Medicines
- صفحه:99-106
WHO Recommendations for the production, control and regulation of human plasma for fractionation
- صفحه:197-198
Worldwide Supply and Demand of Plasma And Plasma-Derived Medicines
- صفحه:111-120
Copyright 2023
Islamic World Science Citation Center
All Rights Reserved
